Bioregulators & Peptides Summit - Chapter 2
Peptide Update: What the FDA Peptide Hearings Mean
Bioregulators & Peptides Summit Playlist
Exosomes, Stem Cells, and the Next Generation of Skin Health
Jordan Plews
How Peptides and Bioregulators May Support Thyroid Healing
Anshul Gupta, MD, IFMCP, FAIHM
The Bioregulator Stacks That May Change Aging Medicine
Kent Holtorf, MD
Peptide Update: What the FDA Peptide Hearings Mean
Elizabeth Yurth, MD, ABPRM, ABAARM, FAARM, FSSRP
How to Prepare Your Body for Better Peptide Results
Scott Sherr, MD
The Genetic Switch: Peptide Bioregulators and the Russian Science of Longevity
Phil Micans, PhD
The Nobel Prize-Winning Molecule for Cellular Resilience
Chris Burres
The New Skincare Strategy for Cellular Repair
Dianka Arcos
Guaranteed safe & secure checkout
All Access Pass to all DrTalks Summits. Includes over 2,243+ health-altering interviews from real doctors and health experts, with 75+ added every month. Renews annually at $97/year. Cancel any time
UNLOCK INSTANT ACCESS8 hours ago
- Discover what the latest FDA peptide proceedings may mean for BPC-157, TB-500, MOTS-c, and other compounds sitting in regulatory limbo.
- Learn how BPC-157 and TB-500 may support musculoskeletal repair, blood flow, inflammation balance, tissue healing, and recovery when used appropriately.
- Uncover why peptide safety depends on context, including patient selection, dosing, cycle length, mitochondrial health, and whether the body’s terrain is ready to heal.
Comments